EGFR is overexpressed in many tumors of epithelial origin, such as non-small cell lung cancer, breast cancer, glioma, head and neck cancer, cervical cancer, bladder cancer, and gastric cancer. Here, EGFR is linked to urinary bladder carcinoma.